L. Thabane, G. Wells, R. Cook, R. Platt, J. Pogue, E. Pullenayegum, D. Matthews, T. McCready, P. Devereaux, J. Cairns and 1 other author(s). Trials, (January 2011)6243<m:linebreak></m:linebreak>GR: Canadian Institutes of Health Research/Canada; JID: 101263253; OID: NLM: PMC3049182; 2010/11/14 received; 2011/02/18 accepted; 2011/02/18 aheadofprint; epublish;<m:linebreak></m:linebreak>Recursos/Organització; Consulting.
Y. Wang, L. Meyerson, Y. Tang, and N. Qian. Journal of the neurological sciences, 285 (1-2):
206-11(October 2009)5489<m:linebreak></m:linebreak>JID: 0375403; 0 (Antibodies, Monoclonal); 0 (Immunologic Factors); 0 (natalizumab); 2009/03/05 received; 2009/07/15 revised; 2009/07/22 accepted; 2009/08/25 aheadofprint; ppublish;<m:linebreak></m:linebreak>Anàlisi de dades; Count data.
P. Vavken, K. Heinrich, C. Koppelhuber, S. Rois, and R. Dorotka. Clinical orthopaedics and related research, 467 (12):
3334-9(December 2009)5892<m:linebreak></m:linebreak>LR: 20101202; JID: 0075674; OID: NLM: PMC2772925; 2008/10/17 received; 2009/03/16 accepted; 2009/03/31 aheadofprint; ppublish; Interessant Figura 1 de la relació entre significació estadística i mida de l'efecte<m:linebreak></m:linebreak>Límits de confiança.
P. Nieminen, J. Carpenter, G. Rucker, and M. Schumacher. BMC medical research methodology, (January 2006)4347<m:linebreak></m:linebreak>LR: 20071115; PUBM: Electronic; DEP: 20060901; JID: 100968545; PMC1570136; 2006/04/17 received; 2006/09/01 accepted; 2006/09/01 aheadofprint; epublish;<m:linebreak></m:linebreak>Publicació.